Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotrophic Keratopathy”

46 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 46 results

Not applicableStudy completedNCT06482164
What this trial is testing

The THINK Study Incidence of Neurotrophic Keratopathy)

Who this might be right for
Dry Eye
Research Insight LLC 31
Post-approval studies (Phase 4)UnknownNCT06331910
What this trial is testing

Efficacy and Safety of Topical Insulin for Neurotrophic Corneal Ulcers

Who this might be right for
Neurotrophic Keratopathy
Assiut University 14
Not applicableStudy completedNCT04293549
What this trial is testing

An 8-week Follow-up to Evaluate the Renewal of Corneal Nerves Structure and Function in Patients With Neurotrophic Keratopathy Treated With Recombinant Human Nerve Growth Factor (rhNGF) Eyedrops

Who this might be right for
Neurotrophic Keratopathy
G. d'Annunzio University 18
Large-scale testing (Phase 3)WithdrawnNCT05321251
What this trial is testing

Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.

Who this might be right for
Neurotrophic Keratitis
University of Alberta
Not applicableTemporarily pausedNCT05758753
What this trial is testing

QST for Corneal Nerve Function

Who this might be right for
Corneal DiseaseNeuropathyDry Eye Disease+1 more
Tufts Medical Center 108
Testing effectiveness (Phase 2)Study completedNCT01756456
What this trial is testing

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis.

Who this might be right for
Neurotrophic KeratitisKeratitisCorneal Ulcer
Dompé Farmaceutici S.p.A 174
Not applicableLooking for participantsNCT04604834
What this trial is testing

Autologous Platelet-rich Plasma (APRP) in the Treatment of Neurotrophic Keratopathy

Who this might be right for
Neurotrophic Keratopathy
Universidad Autonoma de Nuevo Leon 39
Testing effectiveness (Phase 2)Looking for participantsNCT06919081
What this trial is testing

Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease

Who this might be right for
Persistent Corneal Epithelial DefectCorneal Epithelial Disorders
University of Illinois at Chicago 24
Testing effectiveness (Phase 2)Study completedNCT02227147
What this trial is testing

Evaluation of Efficacy of 20 µg/ml rhNGF New Formulation (With Anti-oxidant) in Patients With Stage 2 and 3 NK

Who this might be right for
Neurotrophic Keratitis
Dompé Farmaceutici S.p.A 48
Not applicableUnknownNCT06412718
What this trial is testing

Validation of Human Drugs Target of Repurposed Drugs and Novel Therapies

Who this might be right for
Rare DiseasesAniridiaNeurotrophic Keratopathy+5 more
IRCCS Ospedale San Raffaele 274
Not applicableNot Yet RecruitingNCT07694817
What this trial is testing

Clinical Predictors of Visual Outcome in Patients Affected With Ocular Surface Diseases

Who this might be right for
Neurotrophic KeratopathyExposure KeratopathyLimbal Stem Cell Deficiency (LSCD)+3 more
IRCCS San Raffaele 1,000
Large-scale testing (Phase 3)Ended earlyNCT02600429
What this trial is testing

Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1

Who this might be right for
Neurotrophic Keratopathy
ReGenTree, LLC 18
Not applicableUnknownNCT04573647
What this trial is testing

OCT Evaluation of Neurotrophic Ulcer Following Treatment With Oxervate

Who this might be right for
Neurotrophic UlcerNeurotrophic KeratitisNeurotrophic Corneal Ulcer+1 more
Sight Medical Doctors PLLC 10
Testing effectiveness (Phase 2)Study completedNCT07120308
What this trial is testing

To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

Who this might be right for
Corneal Epithelial Defect
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. 28
Not applicableStudy completedNCT04820010
What this trial is testing

Topical Insulin - Utility and Results in Neurotrophic Keratopathy in Stages 2 and 3

Who this might be right for
Corneal UlcerCorneal PerforationCorneal Epithelium Defect+1 more
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. 20
Testing effectiveness (Phase 2)Study completedNCT04276558
What this trial is testing

REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients

Who this might be right for
Neurotrophic Keratitis
RECORDATI GROUP 108
Not applicableStudy completedNCT04552730
What this trial is testing

Nerve Growth Factor for the Treatment of Cornea Disease

Who this might be right for
Neurotrophic Keratitis
Stanford University 5
Not applicableEnded earlyNCT05809245
What this trial is testing

Corneal Neurotization as a Treatment for Neurotrophic Keratopathy

Who this might be right for
Neurotrophic Corneal UlcerNeurotrophic KeratitisCranial Nerve V Diseases
Stanford University 4
Testing effectiveness (Phase 2)Study completedNCT02592330
What this trial is testing

Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft

Who this might be right for
Limbal Stem Cell Deficiency
Massachusetts Eye and Ear Infirmary 23
Testing effectiveness (Phase 2)Looking for participantsNCT05927428
What this trial is testing

Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis

Who this might be right for
Neurotrophic Keratitis
BRIM Biotechnology Inc. 12
Next Page